Showing results (1-10 of 288) with videos related to
Sort By:
Pageof 29
Blood Advances|January 10, 2019
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemiaJoseph Wynne, David Wright, Wendy StockCurrent Hematologic Malignancy Reports|September 13, 2020
New Approaches to Treating Challenging Subtypes of ALL in AYA PatientsKevin Prescott, Michael Jacobs, Wendy Stock, et al.Leukemia & Lymphoma|November 5, 2019
Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaBenjamin A Derman, Mitchell Streck, Joseph Wynne, et al.Hematology. American Society of Hematology. Education Program|November 25, 2006
Controversies in treatment of AML: case-based discussionWendy StockLeukemia & Lymphoma|December 17, 2009
Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaWendy StockHematology. American Society of Hematology. Education Program|January 18, 2011
Adolescents and young adults with acute lymphoblastic leukemiaWendy StockBlood|February 24, 2019
Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALLEmily Curran, Wendy StockCurrent Opinion in Hematology|June 10, 2008
Progress in the treatment of adults with acute lymphoblastic leukemiaSarah Larson, Wendy StockBlood|March 26, 2015
How I treat acute lymphoblastic leukemia in older adolescents and young adultsEmily Curran, Wendy StockHematology. American Society of Hematology. Education Program|December 10, 2017
Progress in adult ALL: incorporation of new agents to frontline treatmentJessica Leonard, Wendy StockPageof 29